ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $840 | -74.1% | 6,366 | 0.0% | 0.00% | – |
| Q2 2023 | $3,246 | -97.7% | 6,366 | -97.1% | 0.00% | – |
| Q1 2022 | $143,000 | -40.4% | 218,978 | -0.7% | 0.00% | – |
| Q4 2021 | $240,000 | -41.3% | 220,495 | -2.0% | 0.00% | -100.0% |
| Q3 2021 | $409,000 | -29.1% | 224,909 | +2.9% | 0.00% | 0.0% |
| Q2 2021 | $577,000 | -41.4% | 218,620 | -20.1% | 0.00% | 0.0% |
| Q1 2021 | $984,000 | +32.3% | 273,471 | -7.4% | 0.00% | 0.0% |
| Q4 2020 | $744,000 | +10.9% | 295,291 | +10.9% | 0.00% | 0.0% |
| Q3 2020 | $671,000 | -33.8% | 266,170 | -13.9% | 0.00% | -50.0% |
| Q2 2020 | $1,014,000 | +104.0% | 309,022 | +52.2% | 0.00% | +100.0% |
| Q1 2020 | $497,000 | -48.8% | 203,034 | -1.3% | 0.00% | -50.0% |
| Q4 2019 | $971,000 | +12.1% | 205,625 | +1.6% | 0.00% | 0.0% |
| Q3 2019 | $866,000 | -27.1% | 202,381 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $1,188,000 | +78.4% | 203,741 | +17.8% | 0.00% | +100.0% |
| Q1 2019 | $666,000 | +103.7% | 172,945 | -1.2% | 0.00% | 0.0% |
| Q4 2018 | $327,000 | -14.4% | 175,080 | +46.5% | 0.00% | 0.0% |
| Q3 2018 | $382,000 | -1.8% | 119,501 | -7.3% | 0.00% | 0.0% |
| Q2 2018 | $389,000 | -20.8% | 128,850 | +2.8% | 0.00% | 0.0% |
| Q1 2018 | $491,000 | -8.4% | 125,309 | -3.3% | 0.00% | 0.0% |
| Q4 2017 | $536,000 | -42.9% | 129,534 | -15.3% | 0.00% | -50.0% |
| Q3 2017 | $939,000 | -0.1% | 153,006 | +1.3% | 0.00% | 0.0% |
| Q2 2017 | $940,000 | +3.6% | 151,096 | +5.6% | 0.00% | 0.0% |
| Q1 2017 | $907,000 | +22.7% | 143,067 | +3.5% | 0.00% | 0.0% |
| Q4 2016 | $739,000 | -4.2% | 138,193 | +1.0% | 0.00% | 0.0% |
| Q3 2016 | $771,000 | +2.9% | 136,860 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $749,000 | -15.5% | 136,450 | +14.2% | 0.00% | -33.3% |
| Q1 2016 | $886,000 | -10.6% | 119,437 | +0.2% | 0.00% | 0.0% |
| Q4 2015 | $991,000 | +5.4% | 119,204 | +14.3% | 0.00% | 0.0% |
| Q3 2015 | $940,000 | -24.0% | 104,279 | +1.2% | 0.00% | -25.0% |
| Q2 2015 | $1,237,000 | +37.8% | 103,089 | +23.7% | 0.00% | +33.3% |
| Q1 2015 | $898,000 | +165.7% | 83,364 | +25.0% | 0.00% | +200.0% |
| Q4 2014 | $338,000 | +97.7% | 66,689 | +3.1% | 0.00% | 0.0% |
| Q3 2014 | $171,000 | -34.5% | 64,714 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $261,000 | -6.1% | 64,714 | +6.7% | 0.00% | 0.0% |
| Q1 2014 | $278,000 | +1.8% | 60,639 | -3.8% | 0.00% | 0.0% |
| Q4 2013 | $273,000 | +10.1% | 63,009 | +0.3% | 0.00% | 0.0% |
| Q3 2013 | $248,000 | +89.3% | 62,809 | +0.5% | 0.00% | – |
| Q2 2013 | $131,000 | – | 62,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |